Shares of Johnson Matthey (OTCMKTS:JMPLY – Get Rating) have received an average recommendation of “Hold” from the thirteen analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $2,404.00.
Several research firms have recently weighed in on JMPLY. JPMorgan Chase & Co. lowered their price objective on shares of Johnson Matthey from GBX 2,800 ($36.49) to GBX 2,600 ($33.88) in a research report on Friday, January 14th. Barclays lowered their price objective on shares of Johnson Matthey from GBX 2,510 ($32.71) to GBX 2,320 ($30.23) and set an “underweight” rating on the stock in a research report on Friday, January 14th. Jefferies Financial Group upgraded shares of Johnson Matthey from an “underperform” rating to a “hold” rating in a research report on Friday, March 18th. UBS Group lowered their price objective on shares of Johnson Matthey from GBX 1,875 ($24.43) to GBX 1,800 ($23.46) in a research report on Monday, April 4th. Finally, Zacks Investment Research cut shares of Johnson Matthey from a “buy” rating to a “hold” rating in a research report on Tuesday, February 15th.
Johnson Matthey stock opened at $50.45 on Thursday. Johnson Matthey has a 52 week low of $46.01 and a 52 week high of $95.72. The stock has a 50-day simple moving average of $49.71 and a 200 day simple moving average of $57.13.
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Articles
- Get a free copy of the StockNews.com research report on Johnson Matthey (JMPLY)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- Array Technologies Stock Giving Another Ground Floor Entry
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.